New immune cell therapy tested for kids with tough cancers
NCT ID NCT03420963
Summary
This early-stage study tested a new treatment for children and young adults whose solid tumors had returned or stopped responding to standard therapies. Researchers gave patients a combination of chemotherapy drugs followed by immune cells (NK cells) donated from umbilical cord blood. The main goal was to find a safe dose and understand the side effects of this combined approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.